# Saw Palmetto for Hair Loss in Women: Evidence & Safe Use > Saw palmetto modestly inhibits DHT and may reduce hair shedding in women. *Saw palmetto (Serenoa repens) is a botanical 5-alpha reductase inhibitor that reduces dihydrotestosterone (DHT) by an estimated 30–40%, potentially slowing androgenetic hair loss in women. Recent placebo-controlled trials show meaningful improvements in terminal hair count and density, particularly in menopausal women. Evidence is rated preliminary-to-moderate — stronger than most supplements but weaker than minoxidil. It is not safe in pregnancy or for women trying to conceive due to its shared mechanism with teratogenic 5-alpha reductase inhibitor drugs.* - Canonical: https://beautycomparison.com/saw-palmetto-hair-loss - Reviewed: 2026-06-20 - Publisher: Beauty Comparison (Beauty Comparison Editorial) — independent, brand-neutral ## Key takeaways - Saw palmetto inhibits both type I and type II 5-alpha reductase, reducing scalp DHT by roughly 30–40% — the same mechanism as pharmaceutical finasteride, at lower potency. - A 2023 randomized, placebo-controlled 16-week trial found oral saw palmetto oil reduced hair fall by up to 29% and produced measurable decreases in serum DHT compared to placebo. - A 2026 180-day placebo-controlled trial in menopausal women showed significant placebo-adjusted gains in total terminal hair count and hair density with no treatment-related adverse events. - Current evidence rates saw palmetto as preliminary-to-moderate for hair loss; it is not FDA-approved and is weaker than minoxidil, which has decades of controlled-trial data. - Saw palmetto shares a mechanism with drugs classified Pregnancy Category X — women who are pregnant, trying to conceive, or breastfeeding must not use it without consulting a physician. - Side effects in clinical trials are mild and infrequent: occasional GI discomfort, headache, or dizziness, with no serious adverse events reported at standard doses. ## What Is Saw Palmetto? Saw palmetto is the common name for *Serenoa repens*, a small palm native to the southeastern United States. Its ripe berries contain fatty acids, phytosterols, and polysaccharides that have been used medicinally for centuries. Today, standardized extracts are sold widely as dietary supplements marketed for prostate health, urinary symptoms, and, increasingly, hair loss. For hair purposes, saw palmetto is marketed as a "natural alternative" to pharmaceutical 5-alpha reductase inhibitors (5-ARIs) such as finasteride. Understanding both its genuine evidence and its real limitations is essential for women making informed decisions about hair loss management. --- ## How Saw Palmetto Works for Hair Loss ### The DHT Pathway Androgenetic alopecia (AGA) — the most common cause of patterned hair thinning in women — involves a follicular sensitivity to dihydrotestosterone (DHT), a potent androgen derived from testosterone via the enzyme 5-alpha reductase (5αR). DHT binds androgen receptors in hair follicle cells, gradually miniaturizing follicles over repeated cycles until they can no longer produce visible hair. Saw palmetto appears to competitively inhibit both type I and type II 5-alpha reductase at multiple sites, reducing the conversion of testosterone to DHT. It may also reduce DHT's ability to bind androgen receptors by competing with DHT at the receptor level. Estimates from the literature suggest saw palmetto can reduce DHT levels by approximately **30–40%** — meaningful inhibition, though substantially less than the 60–70% reduction achieved by pharmaceutical finasteride at 1 mg/day. ### Is the Mechanism the Same in Women? Female pattern hair loss (FPHL) is the more accurate term for androgenetic-pattern thinning in women. While androgens play a role, the association is less direct than in men — FPHL can occur in women with entirely normal androgen levels, and the pattern is typically more diffuse, affecting the central parting rather than the hairline and crown. This means the DHT-inhibition rationale is plausible but less mechanistically established in women than in men. --- ## What the Evidence Shows ### 2023 RCT: Oral and Topical Saw Palmetto Oil A 16-week randomized, placebo-controlled trial published in *Clinical, Cosmetic and Investigational Dermatology* enrolled 80 subjects with mild-to-moderate androgenetic alopecia (73 completers). Participants received either a standardized saw palmetto oil (VISPO) orally, topically, or as a combination, or placebo. Key outcomes: - Oral VISPO reduced hair fall by up to **29%** from baseline (p < 0.001) - Topical VISPO reduced hair fall by approximately **22%** (p < 0.01) - Oral administration produced a **marked reduction in serum DHT** compared to placebo (p < 0.001) - Hair density improved in both active groups - No serious adverse effects were observed This is the most methodologically rigorous trial to date, though the 16-week duration and mixed-sex cohort limit generalization to women specifically. ### 2025–2026 Trials: Menopausal Women A pair of publications from Ablon Skin Institute assessed a proprietary bioactive fatty acids extract from *Serenoa repens* (SEREVELLE) in adults with self-perceived thinning hair, with approximately 50% female participants: - **90-day results (2025):** Significant improvement in terminal hair count (anterior p < 0.0007, posterior p < 0.0005) vs. baseline, and significant improvement vs. placebo in both regions. - **180-day results (2026):** In menopausal women specifically, active treatment produced significant placebo-adjusted gains in total terminal hair count (p < 0.05) and total hair density (p < 0.01). No treatment-related adverse events were reported. These are the first trials to explicitly report outcomes in menopausal women — a population underserved by existing hair loss research. ### Comparison with Finasteride (Men) An earlier 24-month study compared saw palmetto extract (~320 mg/day) with finasteride (1 mg/day) in 100 men with mild-to-moderate AGA. Finasteride outperformed saw palmetto: stabilization of hair loss occurred in 52% of the saw palmetto group vs. a higher proportion with finasteride, and finasteride produced more hair growth. This suggests saw palmetto occupies a position of modest-to-moderate efficacy below pharmaceutical 5-ARIs. ### Overall Evidence Rating | Measure | Rating | |---|---| | Mechanism (DHT inhibition) | Established — moderate strength | | RCT evidence in AGA | Preliminary-to-moderate | | RCT evidence in women specifically | Preliminary (2025–2026 trials) | | Head-to-head vs. minoxidil | No direct comparison trial exists | | FDA approval for hair loss | None | --- ## Who May Benefit Most Saw palmetto is most rationally considered for women who: - Have confirmed or suspected androgenetic alopecia (hormonal workup suggested first) - Cannot tolerate or prefer not to use [minoxidil](/[minoxidil](/minoxidil-women-guide)-women-guide) or pharmaceutical 5-ARIs - Are postmenopausal (avoiding the pregnancy risk that applies to reproductive-age women) - Want to use a supplement alongside a primary treatment, with appropriate expectations It is **not a substitute for minoxidil**, which has over three decades of large-scale RCT data and the only FDA approval for hair loss in women. Saw palmetto may be a reasonable adjunct or alternative for women with contraindications to standard treatments — but this should be discussed with a dermatologist. --- ## Safety Profile and Side Effects In clinical trials of up to 6 months' duration, saw palmetto is well tolerated. Side effects are mild and infrequent: - **GI discomfort** (nausea, diarrhea, abdominal cramping) — the most commonly reported - **Headache and dizziness** — reported occasionally - **Rare: changes in libido or menstruation** — theoretical based on the antiandrogenic mechanism; not consistently documented in trials at typical doses No serious adverse events have been reported in clinical trials at standard supplemental doses (typically 160–320 mg of standardized extract daily). ### Drug Interactions Saw palmetto has potential interactions to be aware of: - **Anticoagulants and antiplatelet agents (aspirin, warfarin, NSAIDs):** Case reports suggest saw palmetto may inhibit platelet aggregation; caution is warranted if taking blood-thinning medications. - **Hormonal therapies (estrogen, progesterone, testosterone):** Theoretical interaction via androgenic pathway; inform your prescribing physician. - **Other 5-ARI drugs (finasteride, dutasteride):** Additive DHT suppression; combining is not recommended without medical supervision. --- ## The Critical Safety Warning: Pregnancy and Conception This is non-negotiable: **women who are pregnant, trying to become pregnant, or breastfeeding must not use saw palmetto.** Saw palmetto shares its mechanism of action with pharmaceutical 5-alpha reductase inhibitors (finasteride, dutasteride), which are classified as **Pregnancy Category X** — contraindicated in pregnancy due to evidence of fetal harm. 5-alpha reductase inhibitors cause abnormal development of male external genitalia in male fetuses. While saw palmetto has not been directly tested in human pregnancy, its antiandrogenic mechanism carries the same theoretical risk. The National Center for Complementary and Integrative Health (NCCIH) explicitly advises that pregnant and breastfeeding women avoid saw palmetto. If you are of reproductive age and using saw palmetto, use reliable contraception and discuss the risk–benefit assessment with your ob-gyn or dermatologist. --- ## How to Use Saw Palmetto for Hair Loss **Dose:** Clinical trials have used 160–320 mg of standardized *Serenoa repens* extract daily, typically as an oral supplement. Topical formulations are also available and demonstrated efficacy in the 2023 RCT. **Timing:** As with all hair loss treatments, results require consistent, sustained use — minimum 3–6 months before meaningful assessment. The 16-week trial showed DHT reduction and hair fall improvement; the 180-day trial demonstrated continued gains at 6 months. **What to look for on labels:** - "Standardized Serenoa repens extract" (standardization to fatty acid content) - 160 mg or 320 mg per serving - Third-party tested for purity (USP, NSF, or ConsumerLab verification) **What to combine with:** Saw palmetto is often studied and used alongside other scalp actives. No direct combination trial with minoxidil exists, but mechanistically the pathways are distinct (DHT inhibition vs. potassium channel / follicle cycle promotion), so combination use under medical guidance is rational. --- ## Saw Palmetto vs. Other Hair Loss Options for Women | Treatment | Evidence Level | FDA Status | Women's Data | |---|---|---|---| | Minoxidil 2–5% (topical) | Strong (decades of RCTs) | FDA-approved | Yes — female-specific approval | | Oral minoxidil (low dose) | Moderate-strong (RCTs) | Off-label | Growing evidence | | Finasteride | Strong (AGA mechanism) | Not approved for women | Limited; off-label postmenopause only | | Spironolactone | Moderate (antiandrogen) | Off-label | Premenopausal women | | Saw palmetto | Preliminary-to-moderate | None | 2025–2026 trials (menopausal) | | Rosemary oil | Limited (1 RCT vs. min 2%) | None | Not specified | | Biotin | Limited (deficiency only) | None | Mixed | --- ## When to See a Dermatologist Hair loss in women has many causes beyond androgenetics. Before starting any supplement, a dermatologist or trichologist should evaluate: - Pattern and degree of loss (Ludwig/FPHL scale assessment) - Bloodwork: ferritin, TSH, full thyroid panel, DHEA-S, total/free testosterone, vitamin D, B12 - Scalp examination or dermoscopy to exclude telogen effluvium, alopecia areata, or scarring alopecias - Hormonal status (premenopausal vs. menopausal) to guide safe treatment selection Do not self-diagnose androgenetic alopecia and self-treat with 5-ARI supplements without professional evaluation. Many reversible causes of female hair loss — iron deficiency, thyroid dysfunction, telogen effluvium — are unrelated to DHT and will not respond to saw palmetto. Seek prompt medical attention if you experience: - Rapidly accelerating hair loss (>150 strands daily) - Scalp redness, scaling, pain, or scarring - Hair loss associated with systemic symptoms (fatigue, weight change, acne, irregular periods) ## FAQ **Does saw palmetto actually work for women's hair loss in 2026?** The evidence has strengthened meaningfully in 2025–2026. Two placebo-controlled trials of a proprietary Serenoa repens extract showed significant improvements in terminal hair count and density in women, including a 180-day trial specifically reporting gains in menopausal women (p < 0.05 for hair count, p < 0.01 for density). A 2023 RCT also showed a 29% reduction in hair fall and measurable serum DHT reduction with oral saw palmetto oil. Evidence is preliminary-to-moderate — more than most supplements but far less than minoxidil. It is most rationally used by postmenopausal women with androgenetic alopecia who cannot or prefer not to use standard treatments. **Is saw palmetto safe for women to take daily?** In clinical trials up to 6 months' duration, saw palmetto is well tolerated in women. Side effects — mainly mild GI discomfort, headache, and dizziness — are infrequent and resolve on stopping. However, women who are pregnant, trying to conceive, or breastfeeding must avoid it: saw palmetto shares its mechanism with pharmaceutical 5-alpha reductase inhibitors classified as Pregnancy Category X due to risk of harm to a male fetus. Caution is also warranted with anticoagulant medications (aspirin, warfarin). Discuss with your doctor before starting. **How long does saw palmetto take to work on hair loss?** The 2023 RCT showed measurable reductions in hair fall within 16 weeks of consistent use. The 2025–2026 trials demonstrated progressive improvement between 90 and 180 days, with the largest gains at 6 months. Like all hair loss treatments, saw palmetto requires sustained use: hair cycles are measured in months, not weeks. Expect a minimum of 3 months before any visible change, and 6 months for a fair assessment. **Can I take saw palmetto if I'm premenopausal?** With caution and only under medical supervision. The primary concern is pregnancy: saw palmetto has antiandrogenic activity that could theoretically harm a male fetus, just as pharmaceutical 5-ARIs do. If you are of reproductive age and considering saw palmetto, reliable contraception is essential, and a frank discussion with your dermatologist or ob-gyn about the risk–benefit balance is required. The 2025–2026 clinical trials were conducted in menopausal women, which is the population with the clearest safety profile. **How does saw palmetto compare to finasteride for hair loss?** Finasteride is substantially more effective. In a direct 24-month comparison in men with AGA, finasteride outperformed saw palmetto on hair growth endpoints. Finasteride inhibits 5-alpha reductase more completely and consistently than saw palmetto, which achieves an estimated 30–40% DHT reduction vs. 60–70% with finasteride. However, finasteride carries a higher side-effect burden (sexual dysfunction, mood changes, post-finasteride syndrome) and is not approved for use in premenopausal women due to pregnancy risk. Saw palmetto may appeal to women who want partial DHT inhibition with a lower risk profile. **What dose of saw palmetto is used in hair loss studies?** Clinical trials have used 160–320 mg of standardized Serenoa repens extract per day in oral supplement form. The 2023 RCT used a standardized saw palmetto oil; the 2025–2026 trials used a proprietary bioactive fatty acids extract at a specific dose per the manufacturer's protocol. Topical formulations are also available. Look for products standardized to fatty acid content and ideally third-party verified. Do not exceed the manufacturer's recommended dose without medical guidance. ## Sources - Oral and Topical Administration of a Standardized Saw Palmetto Oil Reduces Hair Fall and Improves the Hair Growth in Androgenetic Alopecia Subjects – A 16-Week Randomized, Placebo-Controlled Study — PubMed Central / Clinical, Cosmetic and Investigational Dermatology (2023-11-13): https://pmc.ncbi.nlm.nih.gov/articles/PMC10648974/ - The Safety and Efficacy of a Proprietary Bioactive Fatty Acids Extract From Saw Palmetto (Serenoa repens) for Promoting Hair Growth and Reducing Hair Loss in Adults With Self-Perceived Thinning Hair: 90-Day Results — PubMed Central / Journal of Cosmetic Dermatology (2025-11-01): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12665258/ - The Safety and Efficacy of a Novel Saw Palmetto (Serenoa repens) Extract for Promoting Hair Growth in Adults With Self-Perceived Thinning Hair: 180-Day Results — PubMed Central / Journal of Cosmetic Dermatology (2026-02-01): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12881706/ - Androgenetic Alopecia: Therapy Update — PubMed Central / Dermatology and Therapy (2023-05-01): https://pmc.ncbi.nlm.nih.gov/articles/PMC10173235/ - Saw Palmetto: Usefulness and Safety — National Center for Complementary and Integrative Health (NCCIH): https://www.nccih.nih.gov/health/saw-palmetto - Prototype Focused Monograph: Review of Antiandrogenic Risks of Saw Palmetto Ingestion by Women — NCBI Bookshelf / National Institutes of Health: https://www.ncbi.nlm.nih.gov/books/NBK216069/ - Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review — PubMed Central / Therapeutic Advances in Drug Safety (2016-08-01): https://pmc.ncbi.nlm.nih.gov/articles/PMC5023004/ _Health information, not medical advice._